What is the recommended concentration and dosing regimen for an intravenous aminophylline infusion in a 70‑kg adult, including loading dose, maintenance rate, and adjustments for smokers or patients over 60 years or with hepatic or cardiac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aminophylline Intravenous Infusion: Concentration and Dosing

For a 70-kg adult requiring aminophylline for acute bronchospasm, administer a loading dose of 5.7 mg/kg (approximately 400 mg) as aminophylline infused over 20–30 minutes, followed by a maintenance infusion of 0.5 mg/kg/hr (35 mg/hr), prepared as 500 mg aminophylline in 250 mL D5W (concentration 2 mg/mL), targeting serum theophylline levels of 10–20 mcg/mL. 1, 2, 3

Standard Concentration Preparation

  • Prepare aminophylline as 500 mg in 250 mL of 5% dextrose (D5W), yielding a concentration of 2 mg/mL 4
  • This standardized concentration simplifies flow-rate calculations and reduces medication errors 4
  • Alternative concentrations of 400 mg theophylline (equivalent to 500 mg aminophylline) in 250 mL are also acceptable 4

Loading Dose Administration

  • Administer 5–6 mg/kg aminophylline (or 4.6 mg/kg theophylline equivalent) intravenously over 20–30 minutes 1, 2, 3
  • For a 70-kg adult: 350–420 mg aminophylline (approximately 400 mg is practical) 2, 3
  • Never administer as a rapid IV push—the 20–30 minute infusion time is essential to prevent toxicity including arrhythmias, hypotension, and seizures 2
  • This loading dose achieves a target serum theophylline concentration of approximately 10 mcg/mL (range 6–16 mcg/mL) 3

Critical Caveat for Patients Already on Oral Theophylline

  • If the patient is currently taking oral theophylline, measure serum theophylline concentration before administering IV aminophylline 5, 6
  • In one study, 68% of patients on maintenance theophylline already had therapeutic levels (>10 mcg/mL) and 9% had toxic levels (>20 mcg/mL) when presenting to the emergency room 6
  • Omit or reduce the loading dose if serum theophylline is already therapeutic to avoid toxicity 5, 6

Maintenance Infusion Dosing

Standard Adult (Non-Smoker, Age <60, No Hepatic/Cardiac Disease)

  • Infuse 0.5 mg/kg/hr aminophylline (0.4 mg/kg/hr theophylline equivalent) 2, 3
  • For a 70-kg adult: 35 mg/hr aminophylline 3
  • Using the standard 2 mg/mL concentration: infuse at 17.5 mL/hr 4
  • This achieves steady-state serum concentrations averaging 10 mcg/mL (range 7–26 mcg/mL) 3

Dose Adjustments for Special Populations

Smokers (Tobacco or Marijuana):

  • Increase maintenance rate by approximately 50% due to enhanced clearance 3
  • For a 70-kg smoker: 0.75 mg/kg/hr (approximately 52.5 mg/hr aminophylline) 3

Elderly Patients (>60 Years):

  • Reduce maintenance rate to 0.4 mg/kg/hr aminophylline 2, 3
  • For a 70-kg elderly patient: 28 mg/hr aminophylline 2
  • Theophylline clearance decreases by approximately 30% in elderly adults 3

Hepatic Insufficiency (Cirrhosis, Acute Hepatitis, Cholestasis):

  • Reduce maintenance rate by 50% or more to 0.25 mg/kg/hr or less 3
  • For a 70-kg patient with liver disease: 17.5 mg/hr or less 3
  • Frequent monitoring of serum levels is mandatory 3

Congestive Heart Failure:

  • Reduce maintenance rate by 50% or more to 0.25 mg/kg/hr or less 3
  • The reduction correlates directly with CHF severity 3
  • For a 70-kg patient with CHF: 17.5 mg/hr or less 3

Monitoring Requirements

  • Measure serum theophylline concentration within 5.5 hours after the loading dose 1
  • Check serum levels at 12–24 hour intervals during maintenance infusion 2
  • Target therapeutic range: 10–20 mcg/mL 1, 2, 3
  • Continuous cardiac monitoring is essential during infusion 2
  • Monitor glucose and potassium levels throughout treatment 1
  • Continuous pulse oximetry is recommended 1

Clinical Decision Algorithm

  1. Confirm indication: Aminophylline should only be used for severe bronchospasm resistant to nebulized beta-agonists and systemic corticosteroids after 15–30 minutes of optimal first-line therapy 2

  2. Assess current theophylline use: If patient is on oral theophylline, measure serum level before IV administration 5, 6

  3. Identify risk factors for altered clearance:

    • Age >60 years → reduce dose 2, 3
    • Smoker → increase dose 3
    • Hepatic disease → reduce dose by ≥50% 3
    • CHF → reduce dose by ≥50% 3
  4. Administer loading dose: 5–6 mg/kg over 20–30 minutes (adjust or omit if already on theophylline) 1, 2, 3

  5. Start maintenance infusion: Adjust rate based on patient factors (see above) 2, 3

  6. Monitor closely: Check serum levels, cardiac rhythm, and metabolic parameters 1, 2

Important Safety Considerations

  • Aminophylline exhibits nonlinear elimination kinetics, meaning small dose increases can produce disproportionately large increases in serum concentration 3
  • Make dose adjustments in small increments 3
  • Contraindicated in patients with uncontrolled seizures—aminophylline lowers seizure threshold 1
  • Avoid in patients with active tachyarrhythmias 1
  • Do not mix aminophylline with other drugs in the same IV line, particularly epinephrine, isoproterenol, or norepinephrine 2

Related Questions

What is the typical dose for an aminophylline (theophylline) infusion?
What is the recommended intravenous (IV) aminophylline loading dose and maintenance infusion rate for adults and children, and how should the regimen be adjusted in elderly patients, those with cardiac disease, hepatic or renal impairment, uncontrolled seizures, or severe arrhythmias?
What is the appropriate dose of aminophylline for a smoker?
What is the recommended dose of aminophylline for adults and children?
What is the maximum daily dose of acebrophylline for adults?
What medication should be initiated to treat anxiety in an elderly patient with dementia?
What is the emergency management for a patient with suspected acute chlormequat (chlormequat chloride) poisoning?
After a six‑month drug‑free interval from lisdexamfetamine (Vyvanse), should the patient restart at a lower dose or resume the previous dose?
What is the clinical significance and recommended management of a 67‑year‑old woman with mild leukocytosis (white‑blood‑cell count 13 × 10⁹/L), relative lymphocytosis (17.6 % lymphocytes) and neutropenia (9.7 % neutrophils), normal hemoglobin and hematocrit, who is euthyroid on thyroid hormone replacement therapy (TSH 0.574 mIU/L, free thyroxine 1.26 ng/dL, free triiodothyronine 2.09 pg/mL)?
In knee osteoarthritis, should I use a COX‑2‑selective inhibitor or a non‑selective NSAID, and if a COX‑2 inhibitor, which one (e.g., celecoxib) and what dose; if a non‑selective NSAID, which agent and what dose?
What is the recommended dexamethasone dosing and taper schedule for tuberculous meningitis in adults and children, and how should it be modified in patients with diabetes, hypertension, or gastrointestinal ulcer disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.